"Listing on the Nasdaq is an important milestone for Medivation because Nasdaq is the largest screen-based electronic stock market in the U.S.," said David Hung, M.D., president and chief executive officer of Medivation. "We believe this is a significant step in Medivation's growth that reflects our financial and clinical accomplishments to date."